13.8% weight gain [31].2.10% risk of diabetes [30].00.24% deterioration lipid profile [33,34].34% prevalence of metabolic side effects [33].Withdrawal dyskinesias, increased prolactin levels, weight gain, and other metabolic abnormalities [32,33]. The gene discussed is PRL; the disease is drug-induced dyskinesia.